ACTU vs REGN: Which Stock is Better?
Side-by-side comparison of Actuate Therapeutics, Inc. Common stock and Regeneron Pharmaceuticals Inc in 2026
ACTU
Actuate Therapeutics, Inc. Common stock
—
REGN
Regeneron Pharmaceuticals Inc
$676.69
Key Metrics Comparison
| Metric | ACTU | REGN | Winner |
|---|---|---|---|
| Market Cap | $49.05M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ACTU
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACTU or REGN a better investment?
Comparing ACTU and REGN: Actuate Therapeutics, Inc. Common stock has a market cap of $49.05M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACTU and REGN?
ACTU (Actuate Therapeutics, Inc. Common stock) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACTU or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACTU or REGN?
Both ACTU and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ACTU or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ACTU or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $49.05M for ACTU.
Should I buy ACTU or REGN in 2026?
Both ACTU and REGN have investment merit. ACTU trades at $N/A while REGN trades at $676.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACTU and REGN stock?
Key differences: Market Cap ($49.05M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ACTU or REGN in 2026?
The choice between ACTU and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ACTU and REGN?
ACTU (Actuate Therapeutics, Inc. Common stock) has a market cap of $49.05M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.